$FLNA
Filana Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.800
▼-8.56%-$0.075
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateFilana Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.11 at 08:31 AM on Sep 22, then ran to $1.30 +17% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is FLNA down today? It is at $0.800 (-8.56%), and our scanner flagged it 114 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment FLNA spikes, and full due diligence on FLNA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $FLNA 114 times in the last 30 days. Create a free account to track $FLNA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on FLNA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Latest filing4Insider trade (Form 4)Oct 1, 2026 · 6 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Barry Richard Officer | Bought (open market) | +100K 0.2% of company | added 8.1% | 1.34M | $92K at $0.920 | Sep 30, 26 |
Barry Richard Officer | Bought (open market) | +207K 0.4% of company | added 20% | 1.24M | $186K at $0.900 | Sep 29, 26 |
Barry Richard Officer | Bought (open market) | +93K 0.2% of company | added 9.9% | 1.03M | $78K at $0.840 | Sep 28, 26 |
Anderson Robert Eugene Jr Director | Bought (open market) | +9K 0.02% of company | n/a | 9K | $25K at $2.90 | Nov 24, 25 |
Barry Richard Officer | Bought (open market) | +150K 0.3% of company | added 19% | 938K | $414K at $2.76 | Nov 20, 25 |
Barry Richard Officer | Bought (open market) | +73K 0.2% of company | added 10% | 788K | $202K at $2.75 | Nov 19, 25 |
Cook Robert Christopher Officer | Bought (open market) | +14K 0.03% of company | n/a | 14K | $40K at $2.91 | Sep 30, 25 |
Barry Richard Officer | Bought (open market) | +7K 0.01% of company | added 1.0% | 715K | $16K at $2.28 | Sep 22, 25 |
Barry Richard Officer | Bought (open market) | +47K 0.10% of company | added 7.2% | 708K | $106K at $2.25 | Sep 19, 25 |
Barry Richard Officer | Bought (open market) | +191K 0.4% of company | added 41% | 660K | $406K at $2.13 | Sep 18, 25 |
Schoen Eric Officer | Sold (automatic/other) | -2K | n/a | n/a | $8K at $3.82 | Nov 29, 24 |
Schoen Eric Officer | Sold (automatic/other) | -60K 0.1% of company | sold 84% | 12K | $231K at $3.86 | Nov 29, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on FLNA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
FLNA last traded at $0.800, down 8.56% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Filana Therapeutics, Inc. Common Stock (FLNA) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The FLNA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged FLNA 114 times in the last 30 days.
FLNA (Filana Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $39M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge FLNA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$FLNA discussion
Sign in to ask a question or join the discussion.